Primary Site >> Stomach Cancer

Gene >> LAG3

Journal: Yonago Acta Med. 2015 Mar;58(1):39-44. Epub 2015 Mar 27.
Title: Upregulation of Immune Checkpoint Molecules, PD-1 and LAG-3, on CD4+ and CD8+ T Cells after Gastric Cancer Surgery.
Author: Takaya, Seigo|Saito, Hiroaki|Ikeguchi, Masahide
PMID: 26190896
Journal: Pharmacogenomics J. 2017 Dec;17(6):528-534.
Title: Genetic variations in immunomodulatory pathways to predict survival in patients with locoregional gastric cancer.
Author: Sunakawa, Y|Cao, S|Volz, N B|Berger, M D|Yang, D|Parekh, A|Zhang, W|Matsusaka, S|Ning, Y|Stremitzer, S|Stintzing, S|Sebio, A|Okazaki, S|Wakatsuki, T|Azuma, M|Watanabe, M|Koizumi, W|Wu, A H|Lenz, H-J
PMID: 27241062
Journal: Cancer Biomark. 2018 Sep 7. pii: CBM181278.
Title: Soluble LAG3 acts as a potential prognostic marker of gastric cancer and its positive correlation with CD8+T cell frequency and secretion of IL-12 and INF-gamma in peripheral blood.
Author: Li, Na|Jilisihan, Bulibu|Wang, Wei|Tang, Yong|Keyoumu, Saifuding
PMID: 30223387